Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Transdermal Optical Imaging TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development

NCT06044610 is registered in ClinicalTrials.gov with PepsiCo Global R&D as lead sponsor.

NCT NCT06044610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06044610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Transdermal Optical Imaging TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development
Lead sponsor
PepsiCo Global R&D
Phase
Not applicable
Overall status
Completed
Start date
May 8, 2023
Completion date
November 15, 2023
Enrollment
32 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dehydration